A protein that impacts Alzheimer’s disease offers new opportunities for targeted treatments, although its cell-specific ...

A groundbreaking peer-reviewed Thought Leaders Invited Review article in Brain Medicine (Genomic Press, New York) explores how CD2-associated protein (CD2AP) contributes to Alzheimer's disease (AD), ...

Noise exposure is one of the most significant causes of synapse loss between inner hair cells and auditory nerve fibers, leading to a decline in hearing sensitivity.

The scientists found that aging weakens the connections between different parts of the brain, making it harder for neurons ...

diseases driven by synapse loss and dysfunction. Boost Neuroscience was spun out of the Stanford University lab of Dr. Thomas Südhof, MD. Dr. Südhof was awarded the 2013 Nobel Prize in ...

In a new study, researchers have found that a new chemical compound derived from the herbs could help to combat Alzheimer's disease and provide a new approach to treating the condition in the future ...

Scientists in California have developed a new chemical compound derived from rosemary and sage plants, which has already shown encouraging results in mice with Alzheimer's. The compound, carnosic acid ...

A new study has found that a compound that is derived from herbs - such as rosemary and sage - can help to reverse some of the signs of Alzheimer's disease in mice ...

Gene therapy, biologics, and small-molecule inhibitors hold promise for precise, stage-specific treatments that minimize pathological synapse loss while preserving cognitive function. As research ...